In short. The burden is a course spread across a year and a result that cannot be judged early. What the plan asks in visits and patience, described without quoting money.
Key points
- Not in money, which is a conversation for the consultation.
- Ask how many sessions, across how many months, when the review happens, and at what point the result can honestly be judged.
- A practice that answers in months has thought about the decision rather than about the appointment.
The question patients bring is what it costs, and the honest answer is that the appointment is the smallest part of it. What a course of this substance asks for is a sequence of visits across a year, a long stretch in which nothing looks different, and a result that cannot be judged early however closely it is watched. Those are the terms, and they are worth understanding before the first session rather than after the second.
The visits
The sessions themselves usually run across three to six months, and the spacing is deliberately wider than convenience would suggest. The review at three months sits inside that period and is where the tissue is examined for firm areas as well as for effect. After the course is completed the effect keeps building, so the appointments do not end when the injections do. Judging the result belongs somewhere between six and eighteen months.
The waiting
The waiting is the part patients underestimate. The carrier gives volume on the day and takes it away again over the following weeks, so the area can look unchanged a month after a session in which something clearly happened. That flat stretch is where the course is abandoned, and it is not a sign that the treatment is failing. It is a period the plan should have described in advance, in weeks rather than in vague encouragement.
Ask what the plan costs in months
Not in money, which is a conversation for the consultation. Ask how many sessions, across how many months, when the review happens, and at what point the result can honestly be judged. A practice that answers in months has thought about the decision rather than about the appointment.
The judgement that cannot be hurried
Because the effect develops after the last session and late lumps appear in the same window, the period between six and eighteen months is both the point of judgement and the period of highest uncertainty. A patient who wants an answer at three months will not get one, and a patient who spends those months looking for one will find the experience considerably worse than it needs to be. Standardised photographs taken at fixed points are the only reliable way to see what is happening.
Costs that appear on no price list
- The months in which the area looks no different from before, with no way to speed it up.
- A result that cannot be judged early, and cannot be reversed once it is judged.
- The additional visits if a firm area needs assessment or management months later.
The useful way to frame it is that this is not a purchase but a commitment with a shape: a small number of sessions, a year or more of development, and a decision that cannot be revisited once the material is in. A patient comfortable with that shape will usually be content. A patient comparing appointments on price alone has been sold the smallest part of the decision.
Frequently asked questions
How long is the whole commitment from first session to judgement?
The sessions themselves usually run across three to six months, and the point at which the result can honestly be judged is somewhere between six and eighteen months. The commitment is therefore measured in a year or more rather than in a course of appointments.
What happens if the review at three months shows no change?
That is a fair question to ask before starting, and the answer should be a plan rather than a reassurance. It may be that the effect is developing and the photographs will show it later, or it may be that further sessions are not the answer, in which case the honest step is a different plan.
Can the sessions be compressed to save time?
They can be scheduled closer together and it is a bad idea. Crowding sessions adds to the risk of firm lumps and unevenness without adding to the result, because the material from the previous session is still being integrated. Time is part of how this substance works.
Risks & Limitations
- Irreversibility: there is no dissolving agent for this substance. A lump, an asymmetry or an over-correction is managed over time, with injected treatment, or occasionally by removal, and never switched off.
- Nodules and granulomas — firm lumps or an inflammatory reaction that can appear weeks or months after treatment and may need assessment and treatment rather than simply resolving.
- Unevenness or over-correction. This substance is placed in an area that cannot be dissolved, so over-treatment is harder to correct than under-treatment.
- Firmness under the skin in the first weeks, which is expected and usually settles, but does not always.
- Infection or inflammation at an injection site, which needs prompt assessment rather than waiting.
- Bruising, swelling, tenderness and occasional headache after treatment.
- The volume visible on the day is the carrier rather than the effect. The result develops over months and cannot be judged early, it is not permanent, and the area continues to age.
When to Seek Care
- A firm, growing or painful lump at or near an injection site, appearing weeks or months after treatment — this needs assessment even when it is not painful.
- Redness, warmth, swelling or pus at an injection site, or fever.
- Skin breakdown, blistering, or a dusky or mottled patch over a treated area — seek care immediately.
- Increasing pain, or pain out of proportion to the injection.
- Difficulty breathing, facial swelling or a widespread rash — possible severe reaction; seek emergency care immediately.
References & Further Reading
- American Academy of Dermatology (AAD) — injectable and skin safety information
- American Society of Plastic Surgeons (ASPS) — injectable treatment guidance
- U.S. Food and Drug Administration (FDA) — approved injectable products and safety communications
- National Medical Products Administration (NMPA, China) — approved product status
- Chongqing West District Hospital — Plastic Surgery & Aesthetics Medical Center
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.